Camille Sebaaly - Net Worth and Insider Trading

Camille Sebaaly Net Worth

The estimated net worth of Camille Sebaaly is at least $231 dollars as of 2024-11-07. Camille Sebaaly is the CFO/Secretary of Sunshine Biopharma Inc and owns about 87 shares of Sunshine Biopharma Inc (SBFM) stock worth over $231. Details can be seen in Camille Sebaaly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Camille Sebaaly has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Camille Sebaaly

To

Camille Sebaaly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Camille Sebaaly owns 1 companies in total, including Sunshine Biopharma Inc (SBFM) .

Click here to see the complete history of Camille Sebaaly’s form 4 insider trades.

Insider Ownership Summary of Camille Sebaaly

Ticker Comapny Transaction Date Type of Owner
SBFM Sunshine Biopharma Inc 2022-11-30 director & CFO and Secretary

Camille Sebaaly Latest Holdings Summary

Camille Sebaaly currently owns a total of 1 stock. Camille Sebaaly owns 87 shares of Sunshine Biopharma Inc (SBFM) as of November 30, 2022, with a value of $231.

Latest Holdings of Camille Sebaaly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SBFM Sunshine Biopharma Inc 2022-11-30 87 2.66 231

Holding Weightings of Camille Sebaaly


Camille Sebaaly Form 4 Trading Tracker

According to the SEC Form 4 filings, Camille Sebaaly has made a total of 2 transactions in Sunshine Biopharma Inc (SBFM) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sunshine Biopharma Inc is the acquisition of 15 shares on November 30, 2022, which cost Camille Sebaaly around $22,800.

Insider Trading History of Camille Sebaaly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Camille Sebaaly Trading Performance

GuruFocus tracks the stock performance after each of Camille Sebaaly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Camille Sebaaly is 1.78%. GuruFocus also compares Camille Sebaaly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Camille Sebaaly within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Camille Sebaaly's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Camille Sebaaly

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.44 LIMIT LIMIT LIMIT LIMIT LIMIT

Camille Sebaaly Ownership Network

Ownership Network List of Camille Sebaaly

No Data

Ownership Network Relation of Camille Sebaaly

Insider Network Chart

Camille Sebaaly Owned Company Details

What does Sunshine Biopharma Inc do?

Who are the key executives at Sunshine Biopharma Inc?

Camille Sebaaly is the director & CFO and Secretary of Sunshine Biopharma Inc. Other key executives at Sunshine Biopharma Inc include 10 percent owner Malek Chamoun , 10 percent owner Advanomics Corp , and director & 10 percent owner & CEO and President Steve N. Slilaty .

Sunshine Biopharma Inc (SBFM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunshine Biopharma Inc (SBFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunshine Biopharma Inc (SBFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunshine Biopharma Inc (SBFM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sunshine Biopharma Inc Insider Transactions

No Available Data

Camille Sebaaly Mailing Address

Above is the net worth, insider trading, and ownership report for Camille Sebaaly. You might contact Camille Sebaaly via mailing address: 14464 Gouin W., #b, Montreal A8 H9h 1b1.